Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,982,525 papers from all fields of science
Search
Sign In
Create Free Account
ME1036
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
CP5609
Broader (1)
Carbapenems
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
- 1-Efficacy of ME 1036 against methicillin-resistant Staphylococcus aureus and vancomycin-insensitive S . aureus in a model of hematogenous pulmonary infection
K. Yanagihara
,
Yuriko Ohnishi
,
+13 authors
S. Kohno
2017
Corpus ID: 26345500
ME1036, a novel parenteral carbapenem, was developed for the treatment of MRSA and vancomycin-intermediate S. aureus (VISA). A…
Expand
2011
2011
Correlation of the antimicrobial activity of ME1036 with its binding affinities to the penicillin-binding proteins from Streptococcus pneumoniae strains
Y. Hirai
,
Sho Takahata
,
Keiko Yamada
,
T. Ida
,
K. Maebashi
Journal of antibiotics (Tokyo. )
2011
Corpus ID: 22795299
We have correlated the binding affinities of ME1036, a carbapenem, to the penicillin-binding proteins (PBPs) from Streptococcus…
Expand
2009
2009
ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumonia.
I. Morrissey
,
D. Biek
,
R. Janes
Journal of Antimicrobial Chemotherapy
2009
Corpus ID: 29050828
fer of such strains from animal to meat products, e.g. during slaughtering. The characterization and comparison of plasmids in…
Expand
2009
2009
Boropinic acid, a novel inhibitor of Helicobacter pylori stomach colonization.
E. Touati
,
V. Michel
,
+4 authors
F. Epifano
Journal of Antimicrobial Chemotherapy
2009
Corpus ID: 205146820
1. Sahm D, Draghi D, Thornsberry C. Activity of ME1036, a novel anti-MRSA carbapenem, against Gram-positive and Gram-negative…
Expand
2008
2008
In vitro activity of tigecycline against gram-positive cocci: a multicentre study in Greece.
E. Malli
,
I. Spiliopoulou
,
+16 authors
E. Petinaki
Journal of Antimicrobial Chemotherapy
2008
Corpus ID: 205146257
than imipenem, meropenem and ceftriaxone. Our findings suggest that against these multidrug-resistant pneumococcal isolates, the…
Expand
2008
2008
In Vitro Activity of ME1036 against Streptococcus pneumoniae Non-Susceptible to Amoxicillin and/or Cefotaxime
D. Biek
2008
Corpus ID: 88171319
2005
2005
Therapeutic Effect of ME1036 on Endocarditis Experimentally Induced by Methicillin-Resistant Staphylococcus aureus
J. Nagura
,
K. Kijima
,
+8 authors
M. Yonezawa
Antimicrobial Agents and Chemotherapy
2005
Corpus ID: 35952716
ABSTRACT The efficacy of ME1036, a novel parenteral carbapenem, was compared with that of vancomycin by using a rabbit model of…
Expand
2005
2005
Comparison of activities of beta-lactam antibiotics against Streptococcus pneumoniae with recombinant penicillin-binding protein genes from a penicillin-resistant strain.
Kumiko Maeda
,
T. Ida
,
+6 authors
M. Inoue
Journal of Infection and Chemotherapy
2005
Corpus ID: 7974462
We investigated the antibacterial activities of 19 beta-lactams against three recombinant bacterial strains, in which three…
Expand
2004
2004
In Vitro Activities of ME1036 (CP5609), a Novel Parenteral Carbapenem, against Methicillin-Resistant Staphylococci
Mizuyo Kurazono
,
T. Ida
,
+4 authors
M. Yonezawa
Antimicrobial Agents and Chemotherapy
2004
Corpus ID: 6652168
ABSTRACT ME1036, formerly CP5609, is a novel parenteral carbapenem with a 7-acylated imidazo[5,1-b]thiazole-2-yl group directly…
Expand
2004
2004
In Vitro Activities of ME 1036 ( CP 5609 ) , a Novel Parenteral Carbapenem , against Methicillin-Resistant Staphylococci
Mizuyo Kurazono
,
T. Ida
,
+4 authors
M. Yonezawa
2004
Corpus ID: 42899600
ME1036, formerly CP5609, is a novel parenteral carbapenem with a 7-acylated imidazo[5,1-b]thiazole-2-yl group directly attached…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required